Next-Generation Incretin Mimetics for Metabolic & Endocrine Research Welcome to the Polaris Peptides GLP-1 & GIP Analogues collection. Dispatched from our San Diego hub, this category represents the cutting edge of metabolic research, featuring high-purity Tirzepatide, Semaglutide, and the novel triple-agonist Retatrutide. Every vial is vacuum-sealed and stability-tested to ensure a minimum purity profile of >99% via HPLC verification. These ligands are engineered for in-vitro investigation into insulinotropism, gastric emptying modulation, and the activation of the GLP-1, GIP, and Glucagon receptor pathways.
Filter

Showing the single result

The Evolution of Multi-Receptor Agonism in Metabolic Science

In 2026, the focus of metabolic research has shifted from single-receptor ligands to “Twincretins” and “Triple-Agonists.” Polaris Peptides provides the analytical grade standards required for researchers studying the synergistic effects of multi-hormone activation on cellular energy balance and glucose homeostasis.

Investigating Tirzepatide: The First-in-Class Dual Agonist

As a dual GLP-1 and GIP receptor agonist, Tirzepatide is a primary tool for researchers investigating:

  • Synergistic Insulinotropism: How the combined activation of GIP and GLP-1 receptors enhances insulin secretion compared to single-agonist models.

  • Metabolic Sensitivity: The study of adipocyte signaling and its role in improving systemic metabolic flexibility.

  • Glucagon Modulation: The suppression of postprandial glucagon levels in response to dual-receptor signaling.

The Frontier of Triple Agonism: Retatrutide Our San Diego 

lab is at the forefront of providing Retatrutide, a triple-hormone receptor agonist. Researchers utilize this ligand to study the simultaneous activation of:

  1. GLP-1 Receptor: For appetite regulation and gastric signaling.

  2. GIP Receptor: For improved lipid metabolism and glucose-dependent insulin release.

  3. Glucagon Receptor: To investigate the role of increased energy expenditure and thermogenesis in research models.

Why Purity Defines Metabolic Research Data

In the study of incretin mimetics, trace contaminants can interfere with delicate receptor binding assays. At Polaris Peptides, our Triple-Point Verification (HPLC/MS/NMR) ensures that every vial is free from truncated sequences or residual solvents. By maintaining strict ISO-7 standards in our California facility, we provide researchers with the precision necessary for reproducible data in high-stakes endocrine studies.

Setmelanotide 10mg
Quick View

GLP-1 & GIP Analogues

Setmelanotide 10mg

$60.00